CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioSpace
Original article

Biogen shifts M&A strategy as Apellis acquisition pushes revenue above analyst expectations

Positive
AI Analysis

Summary

Biogen officially began reporting revenue from its $5.6 billion acquisition of Apellis in Q2, exceeding analyst consensus estimates and signaling a shift in M&A strategy.

Financial Highlights

Revenue

beat analyst expectations

Importance:7/10
Sentiment:
0.60
M&Aacquisitionrevenueanalyst consensus
Related Companies

Read the original article

Published by BioSpace on July 29, 2026 2:54 PM

Read Original